Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Oct 1;166(4):1070-83.
doi: 10.1084/jem.166.4.1070.

Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity

Affiliations

Resistance of cloned cytotoxic T lymphocytes to cell-mediated cytotoxicity

A Blakely et al. J Exp Med. .

Abstract

Cloned CTLs show an unusually high resistance to lysis by effector CTLs. Several cloned CTL lines in our laboratories are absolutely refractory to lysis by other cloned CTLs, either (a) directly, (b) in the presence of lectin, or (c) by PMA-induced CTLs. They can be lysed to some extent by primary CTL, although they are less than 5% as sensitive as target cells normally used to assay primary CTL lytic activity. Lysis of cloned CTLs by primary CTL effector cells is not enhanced by the presence of lectin, and cloned T cells are also highly resistant to lysis by primary lymphokine-activated killer cells. Cloned CTLs are highly resistant to lysis by isolated CTL granules that contain the membranolytic pore-forming protein (PFP or perforin), while non-CTL targets are highly susceptible to granule-mediated killing, indicating that cloned CTLs resist lysis not only at the intact effector cell level but also when soluble effector proteins are used. This resistance mechanism may explain how CTLs kill but spare themselves from being killed during the cytolytic event.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Contemp Top Immunobiol. 1977;7:301-61 - PubMed
    1. J Immunol. 1977 Jan;118(1):71-6 - PubMed
    1. Adv Exp Med Biol. 1982;146:533-45 - PubMed
    1. Cancer Res. 1983 Feb;43(2):572-6 - PubMed
    1. J Immunol. 1983 Jun;130(6):2952-9 - PubMed

Publication types